Skip to content

Tag: Jakafi discontinuation syndrome

Explore our medication guides and pharmacology articles within this category.

Understanding What are the Withdrawal Symptoms of Ruxolitinib?

4 min read
Up to 13.5% of patients who discontinue ruxolitinib may experience withdrawal symptoms, highlighting the importance of understanding **what are the withdrawal symptoms of ruxolitinib** and the risks of abrupt cessation. This potentially life-threatening rebound of inflammatory cytokines is known as Ruxolitinib Discontinuation Syndrome (RDS).